Skip to search formSkip to main contentSkip to account menu

FCE 22178

Known as: FCE-22178 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rolafagrel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome
We have previously shown that the administration of a thromboxane A2 (TXA2) synthase inhibitor (FCE 22178) reduced the… 
1990
1990
Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.
Previous studies have demonstrated that inhibition of thromboxane A2-dependent platelet aggregation by the thromboxane A2… 
1989
1989
Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
Previous studies have shown that platelet-activating factor (PAF) receptor blocking has a protective effect on rabbit nephrotoxic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)